Brazil · Delayed Price · Currency is BRL Vitru Educação Earnings Call Transcripts
Fiscal Year 2026
-
Engaged student base and hybrid program growth drove record financial results, with net revenue up 7.7% and adjusted EBITDA margin reaching a historic high. Strong cash generation enabled significant deleveraging, while regulatory changes and a new dividend policy are key focus areas for the future.
-
Student base grew 10% year-over-year, with engagement and hybrid learning intake rising sharply. Adjusted EBITDA margin expanded to 40.6%, net debt fell, and free cash flow surged 85%. Regulatory cost impacts are expected from 2027, while a successful follow-on offering strengthened capital for growth.
Fiscal Year 2025
-
Record student growth and robust financials marked 2025, with net revenue up 5.5% and adjusted EBITDA up 10.1% year-over-year. Strategic focus on hybrid education, operational efficiency, and tax benefits from corporate restructuring position the company for stable margins and strong cash generation in 2026.
-
Student base and revenue grew solidly, with strong margin expansion and cash flow. Leverage improved, and new debt issuance extended maturities. Regulatory changes and competition present challenges, but management expects continued robust performance and potential for shareholder payouts.
-
Surpassed 1 million students and posted strong H1 2025 results, with net revenue up 6.6% and adjusted net income up 75.6% year-over-year. Proactive adaptation to new regulations and robust cash generation support a stable outlook for margins and enrollment.
-
Online education and continuous education segments drove double-digit growth in enrollment and profitability, with adjusted net profit more than doubling year-over-year. Operational efficiency, academic model changes, and a strong hub network position the company for future regulatory shifts.
Fiscal Year 2024
-
Enrollment and revenue grew strongly in 2024, with adjusted EBITDA up 10% and net income up 15.1%. Gross margin declined slightly due to hybrid course ramp-up, but cash flow and deleveraging improved. 2025 guidance expects stable margins and potential dividend distributions.
-
Q3 2024 delivered robust growth, with net revenue up 8.8% and adjusted EBITDA up 9.9% year-over-year, driven by strong performance in distance learning, medicine, and continuing education. The company launched a transformation program to accelerate future growth and received multiple innovation awards.
-
Q2 2024 saw double-digit revenue and EBITDA growth, driven by distance learning and continuing education, despite a student base adjustment from harmonized criteria. Debt maturity was extended, leverage reduced, and profitability improved, with strong innovation and national expansion supporting future growth.